Cleveland BioLabs Inc (CBLI)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

73 HIGH STREET BUFFALO, NY 14203

Cleveland BioLabs, Inc. (CBL) is a development-stage company focused on radiation drug discovery. The Company is engaged in the identification, development and commercialization of new types of drugs for protection of normal tissues from exposure to radiation and other stresses, such as toxic chemicals and cancer treatments. The Company's initial target is to develop a drug to protect humans from the effects of exposure to radiation, whether as a result of military or terrorist acts or as a result of a nuclear accident. Other potential applications of its drug candidates include reducing the side effects of cancer treatment, destroying tumor cells, and generating adult stem cells.

Data based on most recent fiscal year report
Market Cap35.758 Million Shares Outstanding11.28 Million Avg Volume487.434 Thousand
1-Yr BETA vs S&P TR-0.355 Current Ratio4.33 Quick Ratio4.33
View SEC Filings from CBLI instead.
Q2 2018 All Institutions Hedge Funds 1
To trade CBLI now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 16 2 (0.19%)
Aggregate 13F shares on 06/30/2018: 513.795 Thousand 284.505 Thousand
Aggregate 13F shares on 03/31/2018: 488.755 Thousand 273.117 Thousand
Percent change: 5.12% 4.17%
Funds creating new positions:
Funds Adding to an existing position: 5 2
Funds closing out their position: 1
Funds reducing their position: 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBLI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments